Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.270 +0.010 (+0.31%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

February 28, 2024

Via AB Newswire

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

February 27, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Stocks on the Launchpad: The Next 3 Market Sensations ↗

February 27, 2024

Navigate the bullish trend in the market by wagering on these three enticing market sensations likely to become multi-bagger investments

Via InvestorPlace

What's Going On With Ardelyx Stock After Earnings? ↗

February 23, 2024

Ardelyx reported ending 2023 with $184.3 million in cash and investments and expects full-year 2024 U.S. net product sales revenue for Ibsrela to be between $140 million and $150 million. Wedbush...

Via Benzinga

Where Ardelyx Stands With Analysts ↗

February 23, 2024

Via Benzinga

Recap: Ardelyx Q4 Earnings ↗

February 22, 2024

Via Benzinga

How Is The Market Feeling About Ardelyx? ↗

February 08, 2024

Via Benzinga

Wedbush Maintains Outperform Rating for Ardelyx: Here's What You Need To Know ↗

January 12, 2024

Via Benzinga

Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket ↗

February 23, 2024

Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 23, 2024

Via Benzinga

Ardelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 23, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 25 points on Friday.

Via Benzinga

Topics Stocks

Ardelyx Reports Mixed Q4 Results: Earnings Miss, Revenue Beat ↗

February 22, 2024

Ardelyx reported quarterly losses of 12 cents per share which missed the analyst consensus estimate of losses of 10 cents by 20%. The company reported quarterly sales of $34.36 million, beating the...

Via Benzinga

Topics Earnings

Why Ardelyx Stock Is Climbing Higher ↗

January 09, 2024

Via Benzinga

What Analysts Are Saying About Ardelyx Stock ↗

January 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 22, 2024

Via Benzinga

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

February 22, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Analyst Upgrades: 3 Stocks Predicted to Soar In Q2 2024 ↗

February 19, 2024

Pounce on the electric surge of analyst upgrades, guiding you through market uncertainties with considerable aplomb.

Via InvestorPlace

3 Revolutionary Biotech Stocks Poised for 10X Surge ↗

February 19, 2024

Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.

Via InvestorPlace

3 Unstoppable Russell 2000 to Buy in February ↗

February 08, 2024

These are a few companies that are within the Russell 2000 Index that offer investors great returns and a bright future.

Via InvestorPlace

3 Sleeper Stocks Under $15 Ready to Explode by 2029 ↗

February 07, 2024

Discover 3 under-$15 stocks primed for a 2029 explosion, from fintech disruptors to biotech pioneers tackling untreatable rare diseases.

Via InvestorPlace

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗

February 06, 2024

These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.

Via InvestorPlace

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗

February 02, 2024

These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns

Via InvestorPlace

Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

February 01, 2024

Conference call scheduled for 4:30 p.m. Eastern Time

From Ardelyx, Inc.

Via GlobeNewswire

3 Groundbreaking Biotech Stocks to Invest in Now ↗

January 29, 2024

These are several biotech companies for investors seeking unique opportunities for great returns within the industry.

Via InvestorPlace

7 Small-Cap Stocks to Buy for Big Gains in 2024 ↗

January 29, 2024

Small-cap stocks are a great way to diversify your portfolio and set yourself up for some potentially dynamic gains.

Via InvestorPlace

3 mid-caps under $20 that Wall Street loves

January 23, 2024

MarketBeat's Stock Screener tool helped identify these three mid-cap stocks - with very bullish Wall Street sentiment - that are currently under $20 per share

Via MarketBeat

Topics Artificial Intelligence Economy

Ardelyx, Inc. Reports Employment Inducement Grants

January 12, 2024

From Ardelyx, Inc.

Via GlobeNewswire

The 3 Best Under-$10 Stocks to Buy in January 2024 ↗

January 10, 2024

These are a few companies for investors looking for inexpensive options that still offer great earnings potential.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

January 08, 2024

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.